Media & Investors
Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.
Press releases
Click each card below for our latest press releases. For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.
02 Mar 2021
Kuros Biosciences announces MagnetOs sales and distribution agreements across Northern Europe
20 Oct 2020
Kuros announces final result of capital increase – total gross proceeds of CHF 18.6 million raised
Reports & corporate governance
Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.
Analysts
Olav Zilian, MD, PhD, EMBA
Mirabaud Securities Ltd
David Sherman, Ph.D.(AC)
LifeSci Capital
Laura Pfeifer-Rossi
Octavian AG
Please use the button below to view and download Analyst reports
Calendar
| Date | Event |
|---|---|
| Mar 18, 2021 | Kuros will publish its Annual Report for 2020 |
| Apr 19, 2021 | Kuros will hold its Annual Shareholders' Meeting |
| Aug 11, 2021 | Kuros will publish its Half Year Report for H1 2021 |